TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Return 18.15%
This Quarter Return
+24.49%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.63B
AUM Growth
+$415M
Cap. Flow
+$6.14M
Cap. Flow %
0.23%
Top 10 Hldgs %
37.9%
Holding
228
New
11
Increased
45
Reduced
33
Closed
6

Sector Composition

1 Healthcare 95.26%
2 Real Estate 2.74%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
STRO icon
101
Sutro Biopharma
STRO
$86.5M
$4.98M 0.19%
641,268
MTD icon
102
Mettler-Toledo International
MTD
$26.5B
$4.93M 0.19%
6,123
MOH icon
103
Molina Healthcare
MOH
$9.26B
$4.9M 0.19%
+27,536
New +$4.9M
TBPH icon
104
Theravance Biopharma
TBPH
$708M
$4.8M 0.18%
228,836
XNCR icon
105
Xencor
XNCR
$597M
$4.8M 0.18%
148,231
A icon
106
Agilent Technologies
A
$36.4B
$4.64M 0.18%
52,525
ALLK
107
DELISTED
Allakos
ALLK
$4.63M 0.18%
64,397
GBT
108
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.53M 0.17%
71,759
-46,324
-39% -$2.92M
PVLA
109
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$4.49M 0.17%
18,116
ARDX icon
110
Ardelyx
ARDX
$1.58B
$4.21M 0.16%
607,698
DOC icon
111
Healthpeak Properties
DOC
$12.5B
$4.15M 0.16%
150,392
SAGE
112
DELISTED
Sage Therapeutics
SAGE
$4M 0.15%
96,211
XLRN
113
DELISTED
Acceleron Pharma Inc.
XLRN
$3.87M 0.15%
40,606
AMED
114
DELISTED
Amedisys
AMED
$3.85M 0.15%
+19,395
New +$3.85M
EDIT icon
115
Editas Medicine
EDIT
$227M
$3.85M 0.15%
130,201
EXAS icon
116
Exact Sciences
EXAS
$9.73B
$3.83M 0.15%
44,015
+20,882
+90% +$1.82M
ABMD
117
DELISTED
Abiomed Inc
ABMD
$3.82M 0.15%
15,794
-13,722
-46% -$3.31M
SNN icon
118
Smith & Nephew
SNN
$16.4B
$3.8M 0.14%
99,560
RVTY icon
119
Revvity
RVTY
$9.95B
$3.78M 0.14%
38,494
TAK icon
120
Takeda Pharmaceutical
TAK
$48.3B
$3.77M 0.14%
210,146
MNTA
121
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$3.72M 0.14%
111,768
+20,452
+22% +$681K
ICPT
122
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.69M 0.14%
77,067
+42,653
+124% +$2.04M
DCPH
123
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$3.67M 0.14%
61,370
CHRS icon
124
Coherus Oncology, Inc. Common Stock
CHRS
$152M
$3.63M 0.14%
203,103
+91,440
+82% +$1.63M
TRIL
125
DELISTED
Trillium Therapeutics Inc.
TRIL
$3.63M 0.14%
448,049